Bart Barlogie
March 2, 2015
Celgene Gives $10 Million to Myeloma Institute
March 2, 2015 | The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.
Celgene Gift to UAMS Myeloma Institute for Bart Barlogie Center for Molecular Diagnostics Advances the Course of Human Health for Patients with Multiple Myeloma
LITTLE ROCK –The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.
December 10, 2014
UAMS Myeloma Institute’s Barlogie Recognized with Lifetime Achievement Award by Israel Cancer Research Fund
LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) Myeloma Institute’s Bart Barlogie, M.D., Ph.D., recently was honored with the Lifetime Achievement Award from the Chicago Chapter of the Israel Cancer Research Fund (ICRF). Barlogie is a UAMS College of Medicine distinguished professor of medicine and pathology and distinguished clinical scholar. He holds the…
November 24, 2014
UAMS Myeloma Institute’s Barlogie Named Distinguished Professor of Medicine and Pathology
LITTLE ROCK — In recognition of his contributions to ground-breaking translational research and his care of thousands of patients with multiple myeloma, Bart Barlogie, M.D., Ph.D., has been named distinguished professor of medicine and pathology in the College of Medicine of the University of Arkansas for Medical Sciences (UAMS) by resolution of the University of Arkansas Board of Trustees.
April 22, 2014
Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming to Lead UAMS Myeloma Institute
April 22, 2014 | World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).
Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming from London to Lead UAMS Myeloma Institute
LITTLE ROCK – World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).
September 19, 2013
Barlogie Receives Medal from Alma Mater for Myeloma Achievements
The University of Heidelberg in Germany presented a Medal of the Faculty to alumnus and internationally known multiple myeloma pioneer Bart Barlogie, M.D., Ph.D., this summer, honoring his life’s work.
October 1, 2012
Myeloma Institute Celebrates New Home
Oct. 1, 2012 | To Bob Kohler, the new space that houses the Myeloma Institute for Research and Therapy on the University of Arkansas for Medical Sciences (UAMS) campus signifies what his patient experience is all about.
July 13, 2010
UAMS Researchers Uncover Differences in High-Risk Myeloma Cases
July 13, 2010 | Fourteen genes may offer clues as to why multiple myeloma is more aggressive for some patients than for others, say researchers at the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy.